Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

Can EpiSwitch PSE become more than a diagnostic tool in prostate disease management?

By Pallavi Madhiraju on January 25, 2026   Medical Devices & Diagnostics  

Doctors Studio’s ozone pilot shows promising 30-day shifts in prostate biomarkers tracked via EpiSwitch PSE. Could this reshape trial design? Find out.